BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Down 80.1% in October

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a large decrease in short interest in October. As of October 31st, there was short interest totalling 2,800 shares, a decrease of 80.1% from the October 15th total of 14,100 shares. Based on an average daily volume of 91,400 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Stock Down 9.2 %

NASDAQ:BCTXW traded down $0.03 during trading hours on Tuesday, hitting $0.27. The company had a trading volume of 94,722 shares, compared to its average volume of 72,665. BriaCell Therapeutics has a 1 year low of $0.11 and a 1 year high of $2.60. The company has a 50-day moving average of $0.29 and a 200 day moving average of $0.35.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.